Vitamin D Deficiency and Depression: Why Idaho Patients Are at Particular Risk

By Kyle Roth, FNP-BC, APRN, MSN, MHA | Roth Family Medicine and Mental Health | Pocatello, Idaho

Pocatello, Idaho sits at approximately 42.9° north latitude. At this latitude, the sun's angle from October through March is insufficient to trigger meaningful vitamin D synthesis in the skin — even on clear days. Combined with Idaho's cold winters that keep people indoors, this means that a large proportion of Southeast Idaho residents are vitamin D deficient for 5–6 months of every year.

This matters for mental health because vitamin D is not just a bone health nutrient. It is a neuroactive hormone with profound effects on brain function, mood regulation, and neuroplasticity — and its deficiency is strongly associated with depression, fatigue, cognitive impairment, and poor antidepressant response.

Vitamin D is technically a prohormone, not a vitamin. It is produced in the skin in response to UVB radiation and converted to its active form (1,25-dihydroxyvitamin D, or calcitriol) in the kidneys. Calcitriol acts on vitamin D receptors (VDRs) distributed throughout the body — including in the brain.

Vitamin D receptors in the brain are found in:

• The prefrontal cortex (executive function, mood regulation)
• The hippocampus (memory, neuroplasticity, stress regulation)
• The hypothalamus (HPA axis regulation)
• The substantia nigra (dopamine production)
• The cerebellum

This distribution reflects vitamin D's role as a neuroactive hormone that regulates:

• Serotonin synthesis and release
• Dopamine synthesis
• Neuroplasticity and BDNF production
• Neuroinflammation (vitamin D has potent anti-inflammatory effects)
• HPA axis reactivity and cortisol regulation

The association between vitamin D deficiency and depression is well-established:

• Multiple large epidemiological studies demonstrate that low vitamin D levels are associated with significantly higher rates of depression
• A meta-analysis of 31 studies found that vitamin D deficiency was associated with a 2.21-fold increased risk of depression
• Vitamin D deficiency predicts poor antidepressant response — patients with low vitamin D are less likely to respond to SSRIs
• Vitamin D supplementation in deficient patients produces significant improvements in depression scores in multiple randomized controlled trials
• The association is particularly strong for seasonal affective disorder (SAD), which follows the same seasonal pattern as vitamin D levels

Key Reference: Shaffer JA, et al. (2014). Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. Psychosomatic Medicine, 76(3), 190–196.

Vitamin D regulates the expression of tryptophan hydroxylase 2 (TPH2) — the enzyme that converts tryptophan to serotonin in the brain. Vitamin D deficiency reduces TPH2 expression, impairing serotonin synthesis. This directly reduces the substrate for serotonergic antidepressants, potentially explaining why vitamin D deficiency predicts poor SSRI response.

Vitamin D is a potent regulator of the immune system with significant anti-inflammatory effects. Deficiency is associated with elevated inflammatory markers (CRP, IL-6, TNF-α) — the same inflammatory cascade that drives inflammatory depression. Vitamin D supplementation reduces these markers.

Vitamin D promotes the expression of brain-derived neurotrophic factor (BDNF) — the neuroplasticity factor central to antidepressant response and hippocampal health. Deficiency reduces BDNF, impairing the neuroplasticity that antidepressants and ketamine therapy depend on.

Vitamin D receptors in the hypothalamus regulate HPA axis activity. Deficiency is associated with elevated cortisol and increased HPA axis reactivity — contributing to the stress sensitivity and sleep disruption that characterize depression.

Idaho's latitude creates a predictable seasonal pattern of vitamin D deficiency:

October–March: UVB radiation at Idaho's latitude is insufficient for meaningful skin vitamin D synthesis. During these months, dietary and supplemental vitamin D are the only sources.

April–September: Adequate UVB radiation for vitamin D synthesis is available, but only during midday hours (10 AM–3 PM) with significant skin exposure. Sunscreen use, clothing, and indoor work significantly reduce synthesis.

Who is most at risk:

• People who work indoors year-round
• People who use sunscreen consistently
• Older adults (skin efficiency for vitamin D synthesis declines with age)
• People with darker skin (melanin reduces UVB absorption)
• Overweight and obese individuals (vitamin D is sequestered in adipose tissue)
• People with malabsorption conditions (Crohn's, celiac, bariatric surgery)

Studies suggest that 40–60% of the general US population is vitamin D insufficient (levels < 30 ng/mL), with rates significantly higher in northern latitudes during winter months.

The test: 25-hydroxyvitamin D (25-OH vitamin D) — the standard serum test for vitamin D status.

Interpreting results:

• < 20 ng/mL: Deficient — associated with bone disease, immune dysfunction, and significantly elevated depression risk
• 20–29 ng/mL: Insufficient — associated with elevated depression risk and poor antidepressant response
• 30–50 ng/mL: Adequate — meets basic physiological needs
• 50–80 ng/mL: Optimal — the range associated with best mental health outcomes in research

• 100 ng/mL: Potentially toxic — rare with oral supplementation at standard doses

Our recommendation: For patients with depression, we target vitamin D levels of 50–80 ng/mL — the range associated with optimal neurological function and best antidepressant outcomes.

The appropriate supplementation dose depends on baseline levels and individual factors:

• Maintenance (levels 40–60 ng/mL): 2,000–4,000 IU/day
• Repletion (levels 20–40 ng/mL): 4,000–6,000 IU/day
• Aggressive repletion (levels < 20 ng/mL): 6,000–10,000 IU/day, or a loading protocol (50,000 IU weekly for 8–12 weeks)

Vitamin D3 (cholecalciferol) is preferred over D2 (ergocalciferol) — it is more potent and produces more sustained increases in serum levels.

Take with fat: Vitamin D is fat-soluble and is best absorbed when taken with a meal containing fat.

Vitamin K2: When supplementing at higher doses, co-supplementation with vitamin K2 (MK-7 form, 100–200 mcg/day) is recommended to direct calcium to bones rather than soft tissues.

Recheck 25-OH vitamin D levels 8–12 weeks after initiating supplementation to assess response and adjust dosing. Once at target levels, annual monitoring is appropriate.

For patients who can safely increase sun exposure, 15–30 minutes of midday sun (10 AM–3 PM) on arms and legs during summer months can produce 10,000–20,000 IU of vitamin D — far more than typical supplementation doses. This is the most physiologically natural approach.

Seasonal affective disorder (SAD) — depression with a seasonal pattern, typically worsening in fall/winter and remitting in spring/summer — is particularly relevant in Idaho. SAD affects an estimated 4–6% of the US population, with significantly higher rates at northern latitudes.

The seasonal pattern of SAD mirrors the seasonal pattern of vitamin D levels, and vitamin D supplementation has demonstrated benefit for SAD in several clinical trials. However, light therapy (10,000 lux for 20–30 minutes in the morning) remains the first-line treatment for SAD, with strong evidence for both mood improvement and circadian resynchronization.

For Idaho patients with SAD, we typically recommend the combination of:

1. Vitamin D supplementation to maintain levels > 50 ng/mL year-round
2. Morning light therapy (October–March)
3. Antidepressant medication if needed
4. Exercise (particularly outdoor exercise when weather permits)

Should everyone in Idaho take vitamin D? Given Idaho's latitude and the high prevalence of deficiency, we recommend that most adults in Southeast Idaho supplement with at least 2,000 IU/day of vitamin D3 year-round, with testing to guide dosing. This is particularly important for patients with depression, fatigue, or immune dysfunction.

Can vitamin D replace antidepressants? For most patients, vitamin D optimization is a complementary intervention. However, for patients whose depression is significantly driven by vitamin D deficiency — particularly those with seasonal patterns and levels below 20 ng/mL — correcting the deficiency can produce dramatic improvements.

Is vitamin D supplementation safe? Vitamin D toxicity is rare and requires sustained intake of very high doses (typically > 10,000 IU/day for months). At standard supplementation doses (2,000–6,000 IU/day), vitamin D is safe for most adults. Testing guides appropriate dosing.

1. Shaffer JA, et al. Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis. Psychosom Med. 2014;76(3):190–196.
2. Anglin RE, et al. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry. 2013;202:100–107.
3. Patrick RP, Ames BN. Vitamin D and the omega-3 fatty acids control serotonin synthesis and action. FASEB J. 2015;29(6):2207–2222.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice.

Kyle Roth, FNP-BC, APRN, MSN, MHA | Roth Family Medicine and Mental Health | Pocatello, Idaho | 208-904-4705 | www.rothfamilymed.com